Detailed Information

Cited 33 time in webofscience Cited 38 time in scopus
Metadata Downloads

Effect of DPP-IV Inhibitors on Glycemic Variability in Patients with T2DM: A Systematic Review and Meta-Analysis

Full metadata record
DC Field Value Language
dc.contributor.authorLee, Subin-
dc.contributor.authorLee, Heeyoung-
dc.contributor.authorKim, Yoonhye-
dc.contributor.authorKim, EunYoung-
dc.date.available2020-02-27T02:22:19Z-
dc.date.created2020-02-04-
dc.date.issued2019-09-16-
dc.identifier.issn2045-2322-
dc.identifier.urihttps://scholarworks.bwise.kr/gachon/handle/2020.sw.gachon/1007-
dc.description.abstractGlycemic variability (GV) has been an emerging target for preventing complications related to type 2 diabetes. For reducing GV, DPP-IV inhibitors have shown effectiveness compared to other oral antihyperglycemic drugs (OADs), but systematic evaluation has yet to be existed. A systematic review and meta-analysis of randomized controlled trials (RCTs) were performed to evaluate the effect of DPP-IV inhibitors compared with other OADs, on GV as measured by mean amplitude of glycemic excursions (MAGE). Searches were conducted using Pubmed, EM BASE, and the Cochrane Library, from which eligible studies were retrieved; seven RCTs were included in the analysis. DPP-IV inhibitors were found to significantly reduce MAGE compared to other OADs (mean difference = -14.61; 95% CI = -19.00 to -10.21; p < 0.0001) without significant heterogeneity among sulfonylureas (mean difference = -14.93; 95% CI = -21.60 to -8.26; p < 0.0001). Initial combination therapy with DPP-IV inhibitors more effectively reduced MAGE than stepwise add-on therapies (p = 0.006), although no differences in MAGE were found based on HbA1c values. These findings indicate that DPP-IV inhibitors are promising alternatives for reducing GV in type 2 diabetes patients. However, further studies utilizing larger numbers of patients and longer-term follow-ups are needed.-
dc.language영어-
dc.language.isoen-
dc.publisherNATURE PUBLISHING GROUP-
dc.relation.isPartOfSCIENTIFIC REPORTS-
dc.subjectDIPEPTIDYL PEPTIDASE-4 INHIBITORS-
dc.subjectACUTE GLUCOSE FLUCTUATIONS-
dc.subjectTYPE-2 DIABETES ROLE-
dc.subjectOXIDATIVE STRESS-
dc.subjectMETFORMIN-
dc.subjectSULFONYLUREA-
dc.subjectCOMPLICATIONS-
dc.subjectVILDAGLIPTIN-
dc.subjectINFLAMMATION-
dc.subjectGLIMEPIRIDE-
dc.titleEffect of DPP-IV Inhibitors on Glycemic Variability in Patients with T2DM: A Systematic Review and Meta-Analysis-
dc.typeArticle-
dc.type.rimsART-
dc.description.journalClass1-
dc.identifier.wosid000485861500021-
dc.identifier.doi10.1038/s41598-019-49803-9-
dc.identifier.bibliographicCitationSCIENTIFIC REPORTS, v.9-
dc.identifier.scopusid2-s2.0-85072291865-
dc.citation.titleSCIENTIFIC REPORTS-
dc.citation.volume9-
dc.contributor.affiliatedAuthorLee, Heeyoung-
dc.type.docTypeArticle-
dc.subject.keywordPlusDIPEPTIDYL PEPTIDASE-4 INHIBITORS-
dc.subject.keywordPlusACUTE GLUCOSE FLUCTUATIONS-
dc.subject.keywordPlusTYPE-2 DIABETES ROLE-
dc.subject.keywordPlusOXIDATIVE STRESS-
dc.subject.keywordPlusMETFORMIN-
dc.subject.keywordPlusSULFONYLUREA-
dc.subject.keywordPlusCOMPLICATIONS-
dc.subject.keywordPlusVILDAGLIPTIN-
dc.subject.keywordPlusINFLAMMATION-
dc.subject.keywordPlusGLIMEPIRIDE-
dc.relation.journalResearchAreaScience & Technology - Other Topics-
dc.relation.journalWebOfScienceCategoryMultidisciplinary Sciences-
dc.description.journalRegisteredClassscie-
dc.description.journalRegisteredClassscopus-
Files in This Item
There are no files associated with this item.
Appears in
Collections
약학대학 > 약학과 > 1. Journal Articles

qrcode

Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.

Altmetrics

Total Views & Downloads

BROWSE